9 a.m.-10:30 a.m.
Issue Workshops
IW77. Using Audiovisual Technology to Teach Behavioral Sciences Chair: Jonathan S. Davine, M.D.
IW78. The Portrayal of Psychiatry in Recent American Film Chair: Steven E. Pflanz, M.D.
IW79. Innovative Child Programs Designed to Increase Access to Care in Diverse Settings Chair: Radmila Bogdanich, M.A.
IW80. Confidentiality in Overseas Settings: The Prioritization of the Individual Versus the Institution Versus the Community Chair: Herbert L. Campbell, M.D.
IW81. Spiritually Augmented Well-Being Cognitive-Behavior Therapy Chair: Russell F. D'Souza, M.D.
IW82. Psychiatric Issues in Argentina Chair: Michelle B. Riba, M.D.
IW83. Buddhist Teachings and Techniques Applied to Disaster Relief: A Two-Year Follow-Up on Sri Lankan Tsunami Victims Chair: Syed S.A. Naqvi, M.D.
IW84. Minority Mental Health Policy Training: Developing Psychiatric Leaders for Careers About Cultural Competence and Disparities Reduction Chair: Francis G. Lu, M.D.
IW85. Research on Procedural Memory: Practical Applications in Dementia Care Chair: Sheila M. Loboprabhu, M.D.
IW86. Vietnam Veterans and the Iraq War: Is the Past Ever the Past? Chair: Laura C. Kordon, M.D.
IW87. A Role for Self-Awareness, Mindfulness, and Meditation in Psychiatric Education Chair: Robert S. Marin, M.D.
IW88. Frontier Psychiatry: Working With Street-Involved Youth Chair: Seena S. Grewal, M.D.
IW89. Fibromyalgia: Current Understanding and Future Directions Chair: Alan Z.A. Manevitz, M.D.
IW90. Perception and Color in Affective States Chair: Lina I. Augius, M.D., M.P.H.
IW91. Medical Board of California Medical Expert Witness Training Chair: Matthew F. Carroll, M.D.
IW92. Racist Reality: An Assessment of Representations of Minorities in Reality Television Programming Chair: Curley L. Bonds II, M.D.
IW93. The Four As of Collaborative Mental Health Care: Accessible, Accountable, Appropriate, and Affable Chair: John M. Haggarty, M.D.
IW94. Refractory Schizophrenia: Treatment Issues American Association of Practicing Psychiatrists; Chair: Michael Y. Hwang, M.D.
11 a.m.-12:30 p.m.
IW95. Caregivers in Bipolar Families: Patients and Partners in Treatment Chair: Igor I. Galynker, M.D.
IW96. Gender Benders in Forensic Psychiatry Chair: Susan J. Hatters-Friedman, M.D.
IW97. A Stigma of Much Substance: Educational Skills to Enhance Trainees' Attitudes and Approaches to Substance Use and Concurrent Disorders Chair: Heather Flett, M.D.
IW98. Adapting the ACT Model for the Needs of Different Communities: A Comparative Case Study of Two Japanese and Canadian ACT Teams Chair: Wendy S. Chow, M.S.W.
IW99. Clinical Pathways for Mood and Anxiety Disorders Chair: Waguih W. IsHak, M.D.
IW100. Finding Balance: The Application of Yoga to Mental Health Chair: Tara A. Klein, M.D.
IW101. Akathisia: An Elusive Phenomenon Chair: Naveed Iqbal, M.D.
IW102. A Malpractice Lawsuit Primer Chair: Eugene Lowenkopf, M.D.
IW103. Multidisciplinary Treatment of Chronic Pain Chair: Vladimir Bokarius, M.D., Ph.D.
IW104. Addressing the Needs of Community-Dwelling Older Schizophrenic Persons Chair: Carl I. Cohen, M.D.
IW105. From Lab to Clinical Pratice: Biology and Treatment of Depression and Posttraumatic Stress Disorder Chair: Meera Narasimhan, M.D.
IW106. The Ultimate Goal: A Modular Approach to Psychosis? Chair: Wolfgang Gaebel, M.D.
IW107. Case Studies Using Video Playback in Couples' Therapy Chair: Ian E. Alger, M.D.
Scientific and Clinical Reports Session 28. Pharmacotherapy and Personality Disorders
82. Personality Traits and Prophylactic Treatment With Selective Serotonin Reuptake Inhibitors Sabrina J. Khan, M.D.
83. Olanzapine for the Treatment of Borderline Personality Disorder: A Flexible-Dose, 12-Week, Randomized, Double-Blind, Placebo-Controlled Study S. Charles Schulz, M.D.
84. A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study Mary C. Zanarini, Ed.D.
Session 29. Long-Term Outcomes of Schizophrenia
85. A 20-year, Multi-Follow-Up Study of Persecutory Delusions in Schizophrenia Martin Harrow, Ph.D.
86. Relationship Between Neurocognitive Performance and Instrumental Work Functioning in Schizophrenia and Other Disorders: A 20-year Prospective Longitudinal Study Linda S. Grossman, Ph.D.
87. Neurocognition, Complex Social Cognition, and Functional Outcome in Schizophrenia Joseph Ventura, Ph.D.
Session 30. Novel Approaches to Wellness
88. A New Kind of Psychiatry: Information Theory in the 21st Century David A. Rothstein, M.D.
89. Spirituality and Recovery From Panic Attacks Caroline B. Williams, M.D.
90. Fostering Spiritual Values and Well-Being: The Need in Psychiatry Russell F. D'Souza, M.D.
Session 31. Methological Issues in Psychiatric Disorders
91. Joint Crisis Plans for People With Psychosis: Economic Evaluation of an RCT Claire Henderson, M.D.
92. LOCF (Last Observation Carried Forward) and Distortion of Findings in a Psychotopic Drug Clinical Study Alex A. Cardoni, M.S.
93. Comparison of Depression and Personality Ratings by a Patient and Informant Regarding the Patient's Psychopathology Gavi Hollander, D.O.
Session 32. Trauma, Aggression, and Psychopathology
94. Clinical Differences Between Patients With Posttraumatic Stress Disorder With and Without Psychotic Symptoms Brian P Mika, M.D.
95. A Controlled Comparison Study of a yoga Breath-Based Program and a Client-Centered Exposure Therapy for Posttraumatic Stress Disorder and Depression in Survivors of Tsunami Disaster Patricia L. Gerbarg, M.D.
96. Exploratory Factor Analysis of Borderline Personality Disorder Criteria in Hispanic Men and Women With Substance Use Disorders Daniel F. Becker, M.D.
Session 33. Gender Issues in Psychiatric Disorders
97. Suicide Among Female Veterans in the General United States Population Bentson McFarland, M.D.
98. Comparison of Longitudinal Course of Illness Between Women and Men: A 25-year, Multi-Followup Study of Schizophrenia, Other Psychotic Disorders, and Nonpsychotic Depression Cherise Rosen, Ph.D.
99. Diagnostic and Gender Differences in Schizophrenia and Other Psychotic Disorders in First-Episode Psychosis Robert W. Marvin, M.D.
Session 34. Neuroscience and Neuropsychiatry in Mood Disorders
100. Brain-Derived Neurotrophic Factor Levels in Depressed Patients During Antidepressant Treatments Donatella Marazziti, M.D.
101. Information Processing in Bipolar Disorder During Remission Camilo J Ruggero, Ph.D.
102. Mitochondrial Function in the Anterior Cingulate and Treatment Response in MDD Dan V. Iosifescu, M.D.
Session 35. Antidepressants and Mood Disorders: Outcome Studies
103. Impact of Study Design on the Results of Continuation Studies of Antidepressants Mark Zimmerman, M.D.
104. The Effectiveness of Venlafaxine and Its Metabolite in Refractory Depressed Patients Patrick S. Mbaya, M.D.
105. Discontinuation of Antidepressant Prophylaxis—Are There Predictors? Tara M. Pundiak, M.D.